Stocks of cinemas, restaurants, retailers and department stores that were laggards during the lockdown can expect growth after the curfew is relaxed, said analysts from GBS Globlex Securities and Country Group Securities (CGS).
Anvisa de Brasil da luz verde para comenzar las pruebas de ButanVac, pero falta documentación mercopress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from mercopress.com Daily Mail and Mail on Sunday newspapers.
Nouvel état d urgence au Japon, variant inquiétant en Inde …focus sur l actualité internationale medscape.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medscape.com Daily Mail and Mail on Sunday newspapers.
Some 12,100 Brazilians aged 18 or over in the states of Rio Grande do Sul, Rio Grande do Norte and Rio de Janeiro are expected to volunteer for the trials
Brazil s National Health Surveillance Agency (Anvisa) has given the green light to clinical trials on volunteers of a potential anti-Covid-19 vaccine produced by the Chinese laboratory Sichuan Clover Biopharmaceuticals, it was announced.
Anvisa said in a statement phase two and three tests are good to go in the country. Sichuan Clover s drug is produced from a combination of proteins with synthetic adjuvants which boost the body s immune response.
It must be administered in two doses with an interval of 22 days and will be tested in some 12,100 Brazilians aged 18 or over in the states of Rio Grande do Sul, Rio Grande do Norte and Rio de Janeiro, Anvisa explained.